STATE OF NEW YORK
________________________________________________________________________
6386
2011-2012 Regular Sessions
IN ASSEMBLY
March 16, 2011
___________
Introduced by M. of A. N. RIVERA, CRESPO, AUBRY, COOK, ARROYO, McENENY,
ENGLEBRIGHT, P. RIVERA, M. MILLER, CASTRO, STEVENSON, RAMOS, JAFFEE,
ROBERTS -- Multi-Sponsored by -- M. of A. CAMARA, DUPREY, LINARES,
MAISEL, McDONOUGH, MONTESANO, MOYA, ORTIZ, RAIA, J. RIVERA, RODRIGUEZ,
TOWNS -- read once and referred to the Committee on Consumer Affairs
and Protection
AN ACT to amend the education law, in relation to the labeling of
Leuprolide acetate
The People of the State of New York, represented in Senate and Assem-bly, do enact as follows:
1 Section 1. The education law is amended by adding a new section 6811-c
2 to read as follows:
3 § 6811-c. Leuprolide acetate. No pharmacist shall dispense or sell the
4 drug Leuprolide acetate, also known and marketed as Lupron, Lupron
5 Depot, Lupron Depot-Ped, Viadur and Eliqard, unless the container
6 containing such drug provided to the consumer is labeled with the
7 following warning:
8 "CAUTION: This drug could cause adverse reactions including, but not
9 limited to, heart attacks, diabetes, convulsions, excessive bleeding and
10 could lead to death."
11 § 2. This act shall take effect on the first of January next succeed-
12 ing the date on which it shall have become a law.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[] is old law to be omitted.
LBD08549-01-1
